|  | MS | Hyperglycaemia (≥ 5.6 mmol/l) | Abdominal obesity | $TC> >6.2 mmol | *TG ≥ >1.70 mmol | #HDL |
---|---|---|---|---|---|---|---|
Rural | NHP | 5.1 | 12.2 | 20.1 | 4.7 | 13.7 | 33.9 |
 | HP | 24.7 | 23.0 | 34.4 | 9.7 | 22.6 | 41.3 |
 | GP | 10 | 14.9 | 28.2 | 5.9 | 15.9 | 35.8 |
 | ORs | 6.12 | 2.15 | 1.49 | 2.18 | 1.83 | 1.37 |
 | (95% CI) | (3.02 - 12.62) | (1.15 - 3.99) | (0.90 - 2.46) | (0.90 - 5.27) | 1.01-3.32 | (0.84 - 2.22) |
 | p-value | <0.001 | 0.014 | 0.12 | 0.79 | 0.043 | 0.20 |
Semi- urban | Â | Â | Â | Â | Â | Â | Â |
 | NHP | 8.8 | 9.6 | 35.2 | 5.7 | 23.1 | 33.8 |
 | HP | 34.7 | 20.7 | 57.1 | 10.8 | 33.4 | 27.7 |
 | GP | 18.0 | 13.6 | 43.7 | 7.5 | 26.7 | 31.7 |
 | Ors (95% CI) | 5.52 (3.94 - 7.74) | 2.45 (1.69 - 3.57) | 2.66 (2.07 - 3.45) | 1.99 (1.26 - 3.16) | 1.67 (1.26 - 2.21) | 0.75 (0.57 - 0.99) |
 | p-value | <0.001 | <0.001 | <0.001 | 0.003 | <0.001 | <0.043 |
Both communities | NHP | 7.7 | 10.4 | 34.3 | 5.4 | 20.4 | 33.9 |
 | HP | 32.8 | 21.2 | 55.0 | 10.6 | 31.3 | 30.4 |
 | GP | 15.9 | 13.9 | 41.1 | 7.1 | 23.9 | 32.7 |
 | Ors (95% CI) | 5.82 (4.30 - 7.89) | 2.32 (1.69 - 3.18) | 2.35 (1.88 - 2.94) | 2.06 (1.37 - 3.09) | 1.78 (1.38 - 2.28) | 0.85 (0.67 -1.09) |
 | p-value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.20 |